{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:50Z","timestamp":1787020250135,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007102","name":"Zagazig University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007102","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The aim of this work is to evaluate the safety and efficacy of repeated sessions of photo-activated chromophore for keratitis-cross linking (PACK-CXL) window absorption (WA) for the treatment of resistant bacterial keratitis (BK).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>This is a retrospective clinical cohort study. Thirty eyes with clinically suspected and lab-confirmed bacterial keratitis, resistant to appropriate antibiotic therapy- which was modified by sensitivity reports- for 2 weeks with failure of epithelialization for 4 weeks after the standard anti-microbial therapy (SAT) together with one setting of PACK-CXL WA were included. If after the first session of PACK-CXL, there is a start of improvement in the form of reduction of the size of corneal ulcer and stromal infiltrates together with the start of epithelialization on clinical examination and AS-OCT, another session of PACK-CXL WA was performed after one week, and so on, till the complete healing and resolution of bacterial keratitis and confirmation by negative bacterial culture. Identification of the micro-organisms was done by lab study before and after treatment. Corneal healing was evaluated by corneal examination and anterior segment OCT (AS-OCT).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Thirty eyes of 30 patients were recruited in this study. They were 16 males and 14 females, their mean age was 44.3\u2009\u00b1\u20095.38 years. The mean ulcer size was 3.96\u2009\u00b1\u20091.87 (mm\n                      <jats:sup>3<\/jats:sup>\n                      ), while the mean size of stromal infiltrates was 4.52\u2009\u00b1\u20092.24 (mm3). PACK-CXL WA treatment was performed an average of 2.87 times for the 30 eyes. Complete healing and resolution (Successful treatment) was observed in 27 eyes (90%) of cases and failure of epithelialization was observed only in 3 eyes (10%). Complete corneal healing was reported in the second month postoperatively in 90% of eyes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and recommendation<\/jats:title>\n                    <jats:p>PACK-CXL WA may be a promising, non-invasive treatment option for resistant bacterial keratitis. It may have a synergistic effect with standard antimicrobial treatment (SAT). Also, it can overcome the antibiotics resistance that has become rapidly spreading worldwide. Repeated sessions of PACK-CXL WA may be more effective for the treatment of resistant bacterial keratitis till complete epithelialization and resolution of BK than a single session with few complications. However, further prospective and comparative studies to support the results are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12886-023-03080-3","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T07:01:56Z","timestamp":1690354916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Repeated sessions of PACK-CXL WA for the treatment of resistant bacterial keratitis: a retrospective study"],"prefix":"10.1186","volume":"23","author":[{"given":"Mohammed M. Mahdy","family":"Tawfeek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan Mohamed Abdel Hamid","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Bor\u2019i","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M. Nashaat Ali","family":"Rady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"3080_CR1","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/09286580601001347","volume":"14","author":"MJ Bharathi","year":"2007","unstructured":"Bharathi MJ, Ramakrishnan R, Meenakshi R, et al. Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol. 2007;14:61\u20139.","journal-title":"Ophthalmic Epidemiol"},{"key":"3080_CR2","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1097\/ICO.0000000000001498","volume":"37","author":"B Knyazer","year":"2018","unstructured":"Knyazer B, Krakauer Y, Baumfeld Y, et al. Accelerated corneal crosslinking with photoactivated chromophore for moderate therapy-resistant infectious keratitis. Cornea. 2018;37:528\u201331.","journal-title":"Cornea"},{"key":"3080_CR3","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/bjo.79.6.601","volume":"79","author":"TB Gray","year":"1995","unstructured":"Gray TB, Cursons R, Sherwan JF, et al. Acanthamoeba, bacterial, and fungal contamination of contact lens storage cases. Br J Ophthalmol. 1995;79:601\u20135.","journal-title":"Br J Ophthalmol"},{"key":"3080_CR4","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/ICO.0b013e318245c02a","volume":"31","author":"CC Chan","year":"2012","unstructured":"Chan CC, Holland EJ. Infectious keratitis after Boston type 1 kerato-prosthesis implantation. Cornea. 2012;31:1128\u201334.","journal-title":"Cornea"},{"key":"3080_CR5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12016-015-8518-3","volume":"49","author":"E Generali","year":"2015","unstructured":"Generali E, Cantarini L, Selmi C. Ocular involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol. 2015;49:263\u201370.","journal-title":"Clin Rev Allergy Immunol"},{"key":"3080_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.clae.2012.10.082","volume":"36","author":"M Fernandes","year":"2013","unstructured":"Fernandes M, Sharma S. Polymicrobial and microsporidial keratitis in a patient using Boston scleral contact lens for Sjogren\u2019s syndrome and ocular cicatricial pemphigoid. Cont Lens and Anterior Eye. 2013;36:95\u20137.","journal-title":"Cont Lens and Anterior Eye"},{"key":"3080_CR7","first-page":"197","volume":"18","author":"SJ Chew","year":"1992","unstructured":"Chew SJ, Beuerman RW, Assouline M, et al. Early diagnosis of infectious keratitis with in vivo real time confocal microscopy. CLAO J. 1992;18:197\u2013201.","journal-title":"CLAO J"},{"key":"3080_CR8","doi-asserted-by":"publisher","unstructured":"Bor\u2019i A, El-Haig WM. Combined photoactivated chromophore for infectious Keratitis-Corneal Collagen Cross-Linking (PACK-CXL) and therapeutic penetrating keratoplasty for resistant bacterial keratitis. Clin Ophthalmol. 2022;16:273\u2013279. https:\/\/doi.org\/10.2147\/OPTH.S348835.","DOI":"10.2147\/OPTH.S348835"},{"key":"3080_CR9","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/j.jcrs.2007.09.005","volume":"33","author":"N Mamalis","year":"2007","unstructured":"Mamalis N. The increasing problem of antibiotic resistance. J Cat Ref Surg. 2007;33:1831\u20132.","journal-title":"J Cat Ref Surg"},{"key":"3080_CR10","volume-title":"Anti-microbial resistance: global report on Surveillance","author":"World Health Organization","year":"2014","unstructured":"World Health Organization. Anti-microbial resistance: global report on Surveillance. Geneva, Switzerland: World Health Organization; 2014."},{"issue":"1","key":"3080_CR11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.4103\/2008-322X.156122","volume":"10","author":"D Tabibian","year":"2015","unstructured":"Tabibian D, Richoz O, Hafezi F. PACK-CXL: corneal cross-linking for treatment of infectious keratitis. J Ophthalmic Vis Res. 2015;10(1):77\u201380.","journal-title":"J Ophthalmic Vis Res"},{"key":"3080_CR12","doi-asserted-by":"publisher","first-page":"3402","DOI":"10.1167\/iovs.07-1592","volume":"49","author":"SA Martins","year":"2008","unstructured":"Martins SA, Combs JC, Noguera G, Camacho W, Wittmann P, Walther R, et al. Antimicrobial efficacy of riboflavin\/ UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008;49:3402\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3080_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jtos.2013.01.002","volume":"11","author":"F Raiskup","year":"2013","unstructured":"Raiskup F, Spoerl E. Corneal crosslinking with riboflavin and ultraviolet A. I. Principles. Ocul Surf. 2013;11:65\u201374.","journal-title":"Ocul Surf"},{"issue":"4","key":"3080_CR14","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/ICO.0b013e318259c9bb","volume":"32","author":"P Rosetta","year":"2013","unstructured":"Rosetta P, Vinciguerra R, Romano MR, Vinciguerra P. Corneal collagen cross-linking window absorption. Cornea. 2013;32(4):550\u20134.","journal-title":"Cornea"},{"issue":"5","key":"3080_CR15","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1097\/ICO.0b013e318169d698","volume":"27","author":"HP Iseli","year":"2008","unstructured":"Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A\/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008;27(5):590\u20134. https:\/\/doi.org\/10.1097\/ICO.0b013e318169d698.","journal-title":"Cornea"},{"issue":"1","key":"3080_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s10792-012-9633-2","volume":"33","author":"R Sorkhabi","year":"2013","unstructured":"Sorkhabi R, Sedgipoor M, Mahdavifard A. Collagen cross-linking for resistant corneal ulcer. Int Ophthalmol. 2013;33(1):61\u20136. https:\/\/doi.org\/10.1007\/s10792-012-9633-2.","journal-title":"Int Ophthalmol"},{"issue":"6","key":"3080_CR17","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/ICL.0b013e3182960fdf","volume":"39","author":"A Sa\u011flk","year":"2013","unstructured":"Sa\u011flk A, U\u00e7akhan OO, Kanpolat A. Ultraviolet A and riboflavin therapy as an adjunct in corneal ulcer refractory to medical treatment. Eye Contact Lens. 2013;39(6):413\u20135. https:\/\/doi.org\/10.1097\/ICL.0b013e3182960fdf.","journal-title":"Eye Contact Lens"},{"issue":"5","key":"3080_CR18","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.1111\/aos.12115","volume":"91","author":"JS Mattila","year":"2013","unstructured":"Mattila JS, Korsb\u00e4ck A, Krootila K, Holopainen JM. Treatment of Pseudomonas aeruginosa keratitis with combined corneal cross-linking and human amniotic membrane trans-plantation. Acta Ophthalmol. 2013;91(5):e410\u2013411. https:\/\/doi.org\/10.1111\/aos.12115.","journal-title":"Acta Ophthalmol"},{"key":"3080_CR19","doi-asserted-by":"publisher","first-page":"4451","DOI":"10.2147\/OPTH.S284306","volume":"14","author":"R Gulias-Ca\u00f1izo","year":"2020","unstructured":"Gulias-Ca\u00f1izo R, Benatti A, De Wit-Carter G, Hern\u00e1ndez-Quintela E, S\u00e1nchez-Huerta V. Photoactivated Chromophore for Keratitis-Corneal collagen cross-linking (PACK-CXL) improves outcomes of treatment-resistant infectious keratitis. Clin Ophthalmol. 2020;14:4451\u20137. https:\/\/doi.org\/10.2147\/OPTH.S284306.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"3080_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.4103\/djo.djo_84_20","volume":"22","author":"M Tawfeek","year":"2021","unstructured":"Tawfeek M. Photo-activated chromophore for keratitis (PACK-CXL) window absorption (WA) alone versus combined PACK-CXL window absorption and standard anti-microbial therapy (SAT) for treatment of infectious keratitis: a prospective study. Delta J Ophthalmol. 2021;22(2):117\u201323. https:\/\/doi.org\/10.4103\/djo.djo_84_20.","journal-title":"Delta J Ophthalmol"},{"issue":"4","key":"3080_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/ICO.0000000000000375","volume":"34","author":"S Bamdad","year":"2015","unstructured":"Bamdad S, Malekhosseini H, Khosravi A. Ultraviolet A\/riboflavin collagen cross-linking for treatment of moderate bacterial corneal ulcers. Cornea. 2015;34(4):402\u20136. https:\/\/doi.org\/10.1097\/ICO.0000000000000375.","journal-title":"Cornea"},{"issue":"4","key":"3080_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jtos.2019.08.006","volume":"17","author":"DSJ Ting","year":"2019","unstructured":"Ting DSJ, Henein C, Said DG, Dua HS. Photoactivated chromophore for infectious keratitis - corneal cross-linking (PACK-CXL): a systematic review and meta-analysis. Ocul Surf. 2019;17(4):624\u201334. https:\/\/doi.org\/10.1016\/j.jtos.2019.08.006.","journal-title":"Ocul Surf"},{"issue":"1","key":"3080_CR23","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/ICO.0000000000000644","volume":"35","author":"L Papaioannou","year":"2016","unstructured":"Papaioannou L, Miligkos M, Papathanassiou M. Corneal collagen cross-linking for infectious keratitis. Cornea. 2016;35(1):62\u201371.","journal-title":"Cornea"},{"issue":"1","key":"3080_CR24","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1016\/j.ophtha.2018.10.018","volume":"126","author":"A Lin","year":"2019","unstructured":"Lin A, Rhee MK, Akpek EK, Amescua G, Farid M, Garcia-Ferrer FJ, Varu DM, Musch DC, Dunn SP, Mah FS, American Academy of Ophthalmology Preferred Practice Pattern Cornea and External Disease Panel. Bacterial Keratitis Preferred Practice Pattern\u00ae Ophthalmology. 2019;126(1):P1\u2013P55. https:\/\/doi.org\/10.1016\/j.ophtha.2018.10.018.","journal-title":"Bacterial Keratitis Preferred Practice Pattern\u00ae Ophthalmology"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-03080-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-023-03080-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-03080-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T07:03:52Z","timestamp":1690355032000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-023-03080-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3080"],"URL":"https:\/\/doi.org\/10.1186\/s12886-023-03080-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the research ethical committee and the Institutional Review Board (IRB) of the Faculty of Medicine, Zagazig University, Zagazig, Egypt and met the ethical code of the World Medical Association for human experimentation, as stated in the Helsinki Declaration. Written informed consent was obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"333"}}